Clinical trial
An International, Multicentre, Efficacy and Safety Study of I10E in Initial and Maintenance Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
NCT02293460 is registered in ClinicalTrials.gov with Laboratoire français de Fractionnement et de Biotechnologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An International, Multicentre, Efficacy and Safety Study of I10E in Initial and Maintenance Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
- Lead sponsor
- Laboratoire français de Fractionnement et de Biotechnologies
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2015
- Completion date
- September 29, 2017
- Enrollment
- 44 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.
chronic inflammatory demyelinating polyradiculoneuropathy